NOVARTIS FARMACEUTICA, S.A. secures contract for Various medicinal products Supply of the active ingredient PAZOPANIB 400MG COMP and the active ingredient IPTACOPAN 200 MG for the University Hospital of Gran Canaria Dr Negrin

Spain, April 27 -- Spain based NOVARTIS FARMACEUTICA, S.A. has secured contract from Direccion Gerencia Hospital Universitario de Gran Canaria Doctor Negrin for Various medicinal products Supply of the active ingredient PAZOPANIB 400MG COMP and the active ingredient IPTACOPAN 200 MG for the University Hospital of Gran Canaria Dr Negrin. The value of the contract is worth 17000009 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....